Get started
Author

Kamran Khan

Observed names: Dr. Kamran Ahmad Khan, KA Khan, Kamran A Khan, Kamran A. Khan, Kamran Ahmad Khan, Khan, Kamran, kamran Ahmad Khan
Observed institutions: National Institutes of Health, University of Nottingham, Gomal University, Kohat University of Science and Technology, National Institute for Health and Care Research, University of Warwick, University of Oxford, National Human Genome Research Institute, NIHR Evaluation Trials and Studies Coordinating Centre, University of Southampton, Wessex Institute of Technology
ORCID: 0000-0002-4322-9695
Observed ORCIDs: 0000-0002-4322-9695, 0009-0005-4760-8683
OpenAlex ID: A5079737392
Economic costs associated with moderate and late preterm birth: a prospective population‐based study
2015 · KA Khan, S Petrou, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 107
Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT
2018 · Sarah E Lamb, Dipesh Mistry, et al. · Health Technology Assessment · 104
PDF
Mapping EQ-5D Utility Scores from the PedsQL™ Generic Core Scales
2014 · Kamran A. Khan, Stavros Petrou, et al. · PharmacoEconomics · 90
Economic costs associated with moderate and late preterm birth: Primary and secondary evidence
2012 · Stavros Petrou, Kamran Khan · Seminars in Fetal and Neonatal Medicine · 88
Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures
2022 · Joseph Kwon, Louise Freijser, et al. · PharmacoEconomics · 86
PDF
Tacrolimus-Loaded Solid Lipid Nanoparticle Gel: Formulation Development and In Vitro Assessment for Topical Applications
2022 · Abdul Shakur Khan, Kifayat Ullah Shah, et al. · Gels · 68
PDF
Pneumococcal Disease: A Systematic Review of Health Utilities, Resource Use, Costs, and Economic Evaluations of Interventions
2019 · Tinevimbo Shiri, Kamran Khan, et al. · Value in Health · 53
Randomised controlled trial evaluating the effectiveness and cost-effectiveness of ‘Families for Health’, a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years
2017 · Wendy Robertson, Joanna Fleming, et al. · Health Technology Assessment · 51
PDF
Randomised controlled trial and economic evaluation of the ‘Families for Health’ programme to reduce obesity in children
2016 · Wendy Robertson, Joanna Fleming, et al. · Archives of Disease in Childhood · 37
PDF
Cost-effectiveness of adrenaline for out-of-hospital cardiac arrest
2020 · Felix Achana, Stavros Petrou, et al. · Critical Care · 36
PDF
An Overview of the Health Economic Implications of Elective Caesarean Section
2013 · Stavros Petrou, Kamran Khan · Applied Health Economics and Health Policy · 36
Synthesis, Characterization and In Vitro Evaluation of Chitosan Nanoparticles Physically Admixed with Lactose Microspheres for Pulmonary Delivery of Montelukast
2022 · Faqir Ullah, Kifayat Ullah Shah, et al. · Polymers · 33
PDF
Systematic review of economic evaluations of exercise and physiotherapy for patients treated for breast cancer
2019 · Kamran Ahmad Khan, Bruno Mazuquin, et al. · Breast Cancer Research and Treatment · 33
PDF
Preparation and Characterization of Controlled-Release Floating Bilayer Tablets of Esomeprazole and Clarithromycin
2022 · Muhammad Israr, Nicola Pugliese, et al. · Molecules · 28
PDF
Dementia and Physical Activity (DAPA) - an exercise intervention to improve cognition in people with mild to moderate dementia: study protocol for a randomized controlled trial
2016 · Nicky Atherton, Chris Bridle, et al. · Trials · 28
PDF
Mapping between the Roland Morris Questionnaire and Generic Preference-Based Measures
2014 · Kamran A. Khan, Jason Madan, et al. · Value in Health · 28
PDF
Preference-Based Health-Related Quality of Life Outcomes Associated with Preterm Birth: A Systematic Review and Meta-analysis
2019 · Stavros Petrou, Natnaree Krabuanrat, et al. · PharmacoEconomics · 25
PDF
Preparation of Losartan Potassium Controlled Release Matrices and In-Vitro Investigation Using Rate Controlling Agents
2022 · Kamran Ahmad Khan, Gul Majid Khan, et al. · Molecules · 22
PDF
Does Structured Exercise Improve Cognitive Impairment in People with Mild to Moderate Dementia? A Cost-Effectiveness Analysis from a Confirmatory Randomised Controlled Trial: The Dementia and Physical Activity (DAPA) Trial
2018 · on behalf of the DAPA Trial Group, Iftekhar Khan, et al. · PharmacoEconomics - Open · 22
PDF
Towards reducing variations in infant mortality and morbidity: a population-based approach
2016 · David Field, Elaine Boyle, et al. · Programme Grants for Applied Research · 18
PDF
Economic costs and health utility values associated with extremely preterm birth: Evidence from the EPICure2 cohort study
2022 · Felix Achana, Samantha Johnson, et al. · Paediatric and Perinatal Epidemiology · 16
PDF
Adrenaline to improve survival in out-of-hospital cardiac arrest: the PARAMEDIC2 RCT
2021 · Gavin D Perkins, Chen Ji, et al. · Health Technology Assessment · 16
PDF
A Systematic Literature Review of Preference-Based Health-Related Quality-of-Life Measures Applied and Validated for Use in Childhood and Adolescent Populations in Sub-Saharan Africa
2021 · Lucky G. Ngwira, Kamran Khan, et al. · Value in Health Regional Issues · 16
PDF
Preparation and In Vitro Evaluation of Controlled-Release Matrices of Losartan Potassium Using Ethocel Grade 10 and Carbopol 934P NF as Rate-Controlling Polymers
2022 · Kamran Ahmad Khan, Claudia Zizzadoro, et al. · Polymers · 13
PDF
Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain
2016 · Pedro Saramago, Beth Woods, et al. · BMC Medical Research Methodology · 13
PDF
Works count: 76
Citation count: 1,227
H-index: 20
I10-index: 30
Year
Topic
Type